![Lapi](/medicine/news/images/News/Lapi.png)
She is highly involved in myriad national committees and organizations such as the Society of Nuclear Medicine, the Society of Radiopharmaceutical Sciences, the American Chemical Society, the Nuclear Science Advisory Committee and the International Atomic Energy Agency.
“As director of the UAB Cyclotron facility, I am excited to work with a great team to bring online new imaging agents that can help UAB researchers and physicians conduct cutting edge research, diagnose disease and determine effective treatments for our patients,” Lapi said. “By making imaging for oncology, neurology, cardiology and basic science available to the UAB community, our goal is to provide tools to gain insight into the biology of diseases and move towards personalized, precision medicine.”
![McConathy](/medicine/news/images/News/JM1-2.png)
“I am excited to work with a great team of clinicians and researchers to realize full potential of the state-of-the art cyclotron and imagining facilities at UAB. We are poised to make position emission tomography (PET) and molecular imaging much more widely available at the UAB community for basic, transitional and clinical research as well as for patient care,” McConathy said. “Over the next 5 years, I expect UAB to become a leader in molecular imaging technologies that improve detection and guide therapy for a range of illnesses including Alzheimer’s disease and Parkinson’s disease, cancer and cardiovascular disease.”
Before coming to UAB, McConathy was also an associate professor of radiology at Washington University School of Medicine. He served as the co-director of the Radiology Research Residency. He remains actively involved in the development and application of PET tracers for oncology and neuroimaging as well as the use of simultaneous PET/MRI for both clinical indications and research.